You just read:

Torque, a Flagship Pioneering Company, Launches Platform to Develop a New Class of Deep-Primed™ Immune Cell Therapies, Financed with $25M Series A and Led by a Veteran Management Team

News provided by

Torque

Nov 14, 2017, 06:00 EST